Erminne Pharmaceuticals Llp - Company Profile

It is a business services limited liability partnership based in Bangalore South, Karnataka, India, established in 2023.
2023 Bangalore South, Karnataka, India Active
Last Updated:
Access Report
About Erminne Pharmaceuticals Llp

Erminne Pharmaceuticals Llp, a active limited liability partnership, was established on 03 February 2023 in Bangalore South, Karnataka, India. Engaging in commission trade within the business services sector, it holds LLPIN: ABZ-9748. Registered under ROC Roc Bangalore. It has total obligation of contribution of ₹1.00 Cr.

Employing 6 professional, Its leadership includes Nadasha Prabhakaran (Partner), Sreenath Ravi (Designated Partner), Nisha Pothanickal Ulahannan (Designated Partner). Past directors included Nadasha Prabhakaran. Its latest date of accounts and solvency statement 31 March 2025. It is based at Bineeta Plazaa, 73, Kasavanahalli, Haralur Main Rd, Bangalore South, Karnataka, 560102.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ABZ-9748

  • Incorporation Date

    03 February 2023

  • Total Obligation of Contribution

    ₹1.00 Cr

  • ROC Code

    Roc Bangalore

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 1.00 Cr
  • Company Age 3 Year, 8 Days
  • Last Filing with ROC 31 Mar 2025
Company report

Erminne Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Erminne Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Erminne Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Nadasha Prabhakaran Partner 03 Feb 2023 Current
Sreenath Ravi Designated Partner 03 Feb 2023 Current
Nisha Pothanickal Ulahannan Designated Partner 03 Feb 2023 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Erminne Pharmaceuticals Llp.

Enhance accessibility to Erminne Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Erminne Pharmaceuticals Llp revenue growth over time
Erminne Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Erminne Pharmaceuticals Llp?

Unlock access to Erminne Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Erminne Pharmaceuticals Llp?

Unlock and access historical data on people associated with Erminne Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Erminne Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Erminne Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Erminne Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Erminne Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Progress on Erminne Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.

  • Director Appointment

    Progress on Nadasha Prabhakaran was appointed as a Partner was appointed as a Partner on 03 Feb 2023 & has been associated with this company since 3 years 8 days . was documented.

  • Director Appointment

    The activity Sreenath Ravi was appointed as a Designated Partner was appointed as a Designated Partner on 03 Feb 2023 & has been associated with this company since 3 years 8 days . was completed.

  • Director Appointment

    Nisha Pothanickal Ulahannan was appointed as a Designated Partner was appointed as a Designated Partner on 03 Feb 2023 & has been associated with this company since 3 years 8 days . was recorded as a recent event.

  • LLP Incorporation

    Erminne Pharmaceuticals Llp was registered on 03 Feb 2023 with Roc Bangalore & aged 3 years 8 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Erminne Pharmaceuticals Llp?

The LLPIN of Erminne Pharmaceuticals Llp is ABZ-9748.

Where is Erminne Pharmaceuticals Llp headquartered?

Erminne Pharmaceuticals Llp is headquartered at Bineeta Plazaa, 73, Kasavanahalli, Haralur Main Rd, Bangalore South, Karnataka, 560102.

When was Erminne Pharmaceuticals Llp incorporated?

Erminne Pharmaceuticals Llp was incorporated on 03 February 2023.

Who are the current directors of Erminne Pharmaceuticals Llp?

The current directors of Erminne Pharmaceuticals Llp are

What is the primary industry of Erminne Pharmaceuticals Llp?

The primary industry of Erminne Pharmaceuticals Llp is Business Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available